Tag: Rankl inhibitor

Globally, millions of people with specific cancer types face a heightened risk of serious bone problems. The Xgeva injection is a targeted therapy designed to prevent these complications and treat other rare bone conditions by inhibiting a key protein responsible for bone breakdown.

According to the National Osteoporosis Foundation, approximately 10 million Americans have osteoporosis, and another 44 million have low bone mass. For many of these individuals, understanding the meaning of Prolia, a medication designed to increase bone mass, is crucial for managing their condition and preventing fractures.

Bone metastases occur in 30 to 40 percent of patients with lung cancer at the time of diagnosis, leading to significant complications [1.3.9]. When deciding on treatment, a key question arises: **Which is better, Zometa or Prolia?**

According to the National Cancer Institute, Xgeva (denosumab) is a monoclonal antibody used to prevent or treat specific bone problems in cancer patients. It helps to reduce the risk of fractures, spinal cord compression, and other skeletal-related events.